RadNet receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
RadNet Inc (RDNT)
The RadNet share price today is 76.35, view NASDAQ RDNT stock exchange data. Track the latest RadNet share price with real-time updates on RDNT stock performance including market cap, day range, 52-week range and dividend yield. Access RDNT charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
75.84
78.14
52 wk Range
50.82
85.84
RDNT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
75.8478.14
52 wk Range
50.8285.84
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RDNT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
92.88
Upside
+21.64%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
5 analysts have revised their earnings downwards for the upcoming period
RadNet receives Investment Bank Analyst Rating Update- Investing.com
Pro
Form 8K RadNet Inc For: 10 August- Investing.com
- RadNet receives Investment Bank Analyst Rating Update
- Investing.com
Pro - RadNet receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Analyst Ratings
8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 92.88
(+21.64% Upside)
RadNet Inc SWOT Analysis
Imaging Innovato | RadNet's strategic acquisition of iCAD for $103 million positions the company at the forefront of AI-driven diagnostic imaging technology |
Financial Resilience | Despite weather-related challenges, RadNet demonstrates robust performance with revenue beats and raised guidance, showcasing operational adaptability |
Market Valuation | Analyst targets range from $71 to $92 per share, reflecting optimism about RadNet's growth prospects and market positioning in healthcare technology |
Future Growth Drivers | Explore RadNet's potential for margin expansion through operational efficiencies, AI integration, and the acceleration of its DeepHealth segment |
RadNet Inc Earnings Call Summary for Q2/2026
- RadNet Q2 2026 EPS of $0.29 beat estimates by 45%; revenue of $622.7M topped forecasts by 2.08%, driving shares up 6.1% after-hours.
- Total revenue rose 25% YoY to $622.7M; adjusted EBITDA climbed 22.7% to record $99.7M, with imaging center EBITDA margin up 17 basis points.
- Digital health revenue surged 56.5% YoY to $32.4M; annual recurring revenue nearly doubled to $105.5M, expected to reach $140M by year-end.
- Company raised FY 2026 guidance: imaging center revenue to $2.37B-$2.42B, adjusted EBITDA to $345M-$358M, free cash flow to $115M-$125M.
- AI deployment accelerating: 15% of volumes through AI auto-draft by end-2026, targeting over 50% by Q2 2027; new breast ultrasound AI cleared.
Last Updated: 10-08-2026, 09:48 pm
Read Full TranscriptEarnings
Latest Release
10-08-2026
EPS / Forecast
0.29 / 0.20
Revenue / Forecast
622.7M / 610.01M
Compare RDNT to Peers and Sector
Metrics to compare | RDNT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRDNTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −284.5x | 4.2x | −0.4x | |
PEG Ratio | 7.88 | 0.12 | 0.00 | |
Price/Book | 5.5x | 3.4x | 2.6x | |
Price / LTM Sales | 2.6x | 1.2x | 3.1x | |
Upside (Analyst Target) | 25.1% | 17.8% | 47.9% | |
Fair Value Upside | Unlock | 8.2% | 6.3% | Unlock |
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the RadNet (RDNT) Share Price Today?
The RadNet share price today is 76.35.
What is the current RadNet (RDNT) share price and day range?
As of 17-08-2026, the RadNet share price is 76.35, with a previous close of 77.31. The share price has ranged from 75.84 to 78.14 today, while the 52-week range spans from 50.82 to 85.84.
What Is the RadNet Market Cap?
As of today, RadNet market cap is 6.01B.
What Is the RadNet (RDNT) Share Price Target?
The average 12-month share price target for RadNet is 92.88, with a high estimate of 105 and a low estimate of 65. 8 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +21.64% Upside potential.
What Is RadNet's Earnings Per Share (TTM)?
The RadNet EPS (TTM) is -0.27.
When Is the Next RadNet Earnings Date?
RadNet will release its next earnings report on 11-11-2026.
From a Technical Analysis Perspective, Is RDNT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does RadNet Trade On?
RadNet is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for RadNet?
The stock symbol for RadNet is "RDNT."
How Many Times Has RadNet Stock Split?
RadNet has split 1 times.
How Many Employees Does RadNet Have?
RadNet has 9060 employees.
What Is the RDNT Premarket Price?
RDNT's last pre-market stock price is 76.92. The pre-market share volume is 630.00, and the stock has changed by -0.39, or -0.50%.
What Is the RDNT After Hours Price?
RDNT's last after hours stock price is 75.20, the stock has changed by -1.15, or -1.51%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.